Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 overexpressing Non-small Cell Lung Cancer

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: 9c54f57250ae8695e55a11770fc2dd75cd48f6ab
First added on: Apr 23, 2026